IMPORTANT UPDATES

Andrew Reisner, MD

Neurosurgeon

Gender
Male
Language
English

Primary Specialty

Neurosurgery


Other Specialty

Pediatric Neurosurgery


Leadership Titles

Medical Director, Neuro Trauma, Medical Director, Concussion Program


Education

Board Certification
Am Bd Neurological Surgery, Am Bd Pediatric Neurological Surgery
Medical School:
University Of Witwatersrand
Internship:
Johannesburg Hospital
Residency:
Emory University School of Medicine
Emory University School of Medicine
Fellowship:
University of California - San Francisco

Publications

Pubmed Profile

Network


MYchart

Introduction

Andrew Reisner, MD, is a Pediatric Neurosurgeon at Children’s Healthcare of Atlanta and Assistant Professor of Neurological Surgery in the Department of Neurosurgery at Emory University School of Medicine. Dr. Reisner joined Children’s in 1999 and currently serves as the Elaine and John C. Carlos Chair for Neurotrauma as well as Medical Director of Neuro Trauma and Concussion.

Dr. Reisner completed his neurosurgery residency training at Emory University School of Medicine followed by his fellowship training in pediatric neurosurgery at the University of California San Francisco School of Medicine.

Research

Dr. Reisner’s research interests include traumatic brain injury (concussion and severe TBI), brain tumors, radiosurgery and intracranial bleeds in children.

Learn more about the neurotrauma research lab.

Focus of Practice

  • Neurosurgery

Areas of Interest

  • Brain tumors
  • Concussion
  • Gamma knife radiosurgery
  • Hydrocephalus
  • Pituitary disorder/pituitary tumors

Locations

Pediatric Neurosurgery Associates

Medical Office Building at Scottish Rite hospital, 5461 Meridian Mark Rd NE Ste 520 Atlanta, GA 30342 Get Directions 404-785-2900

Childrens Healthcare of Atlanta - Neurosciences

Scottish Rite hospital, 1001 Johnson Ferry Rd NE Atlanta, GA 30342 Get Directions

Featured Media

In the News

Children’s COVID-19 and MIS-C Biomarker Study

No reliable biomarker for predicting COVID-19 and MIS-C severity was available until the Children’s Healthcare of Atlanta Pediatric Neurotrauma Lab serendipitously discovered elevated levels of plasma osteopontin, an inflammatory biomarker they use to follow traumatic brain injuries (TBI) and concussions, were also elevated in COVID-19 positive and MIS-C patients.